Trials / Conditions / Melanoma BRAF V600E/K Mutated
Melanoma BRAF V600E/K Mutated
4 registered clinical trials studyying Melanoma BRAF V600E/K Mutated — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patien NCT07092410 | SRH Wald-Klinikum Gera GmbH | Phase 4 |
| Recruiting | Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Sym NCT06887088 | Grupo Español Multidisciplinar de Melanoma | Phase 2 |
| Active Not Recruiting | Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable NCT06784648 | BioInvent International AB | Phase 1 / Phase 2 |
| Unknown | Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in P NCT02202200 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |